Myvlar
Myvlar is a medicine authorised by Swissmedic under authorisation number 57418. The authorisation holder is Berlis AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 09 June 2005 and the authorisation is valid without a time limit. ATC code G03AA10 places the medicine in the group Sex hormones and modulators of the genital system.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Myvlar, Dragées | B | 09 June 2005 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 x 21 | Dragée(s) | G03AA10 | 09.02.1. | B |
| 3 | 3 x 21 | Dragée(s) | G03AA10 | 09.02.1. | B |
| 5 | 6 x 21 | Dragée(s) | G03AA10 | 09.02.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Myvlar authorised in Switzerland?
Yes. Myvlar is authorised by Swissmedic under authorisation number 57418, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Myvlar have?
Myvlar is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Myvlar?
The authorisation holder is Berlis AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.